Viral vectors for malaria vaccine development
- 1 August 2006
- Vol. 25 (14) , 2567-2574
- https://doi.org/10.1016/j.vaccine.2006.07.035
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican childrenVaccine, 2006
- Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus MonkeysJournal of Virology, 2005
- Posttranslational Modification of RecombinantPlasmodium falciparumApical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine CandidateInfection and Immunity, 2005
- Phase 1 Evaluation of 3 Highly Immunogenic Prime‐Boost Regimens, Including a 12‐Month Reboosting Vaccination, for Malaria Vaccination in Gambian MenThe Journal of Infectious Diseases, 2004
- Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United StatesClinical and Vaccine Immunology, 2004
- Human adenovirus type 35: nucleotide sequence and vector developmentGene Therapy, 2003
- Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 VaccinesJournal of Virology, 2003
- Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus ImmunityJournal of Virology, 2003
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virusJournal of Molecular Biology, 2002